This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
large-cap: Archive
Time to Buy Stock in the World's Most Valuable Company as Earnings Approach?
by Shaun Pruitt
As the world's most valuable company, markets will pay close attention to results for Apple's (AAPL) fiscal third quarter on Thursday, August 1.
AAPLNegative Net Change MSFTNegative Net Change TSMPositive Net Change TSLANegative Net Change
artificial-intelligence cloud-computing computers earnings electronics investing large-cap magnificent-7 tech-stocks
3 Iconic Companies to Buy Stock in After Earnings
by Shaun Pruitt
Glancing at the Zacks Rank #1 (Strong Buy) list, the stocks of three iconic companies are standing out after they were able to exceed Q2 earnings expectations.
GEPositive Net Change HONNegative Net Change TSMPositive Net Change
aerospace earnings interest-rate investing large-cap multi-sector-conglomerates semiconductor tech-stocks transportation
Tesla, Alphabet Kick Off Magnificent Seven Earnings in Mixed Fashion
by Bryan Hayes
All eyes remain on these dominant players as the group has begun to report their second-quarter earnings figures.
TSLANegative Net Change GOOGLNegative Net Change
ad-tech advertising artificial-intelligence autonomous-vehicles earnings electric-vehicles fang investing large-cap magnificent-7 tech-stocks
2 Standout Stocks to Buy After Beating Earnings Expectations
by Shaun Pruitt
Now looks like a promising time to invest in the increased profitability of HCA Healthcare (HCA) and Spotify Technology (SPOT) after beating Q2 earnings expectations on Tuesday.
HCAPositive Net Change SPOTNegative Net Change TSLANegative Net Change GOOGLNegative Net Change
business-services earnings hospitals investing large-cap magnificent-7 medical tech-stocks
4 Large Drug Stocks to Watch as Innovation, M&A Pick Up
by Kinjel Shah
Drug and biotech companies are seeing significant innovation in 2024. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), Merck (MRK) and Pfizer (PFE) are worth retaining in one's portfolio.
LLYPositive Net Change PFEPositive Net Change NVONegative Net Change MRKNegative Net Change
large-cap pharmaceuticals
Top Stocks to Consider After Cooler PCE Data
by Shaun Pruitt
On Friday, Core PCE, the Fed's preferred inflationary measure optimistically reflected a 0.1% uptick in May compared to a 0.3% increase in April.
AMZNNegative Net Change BACNegative Net Change NVDAPositive Net Change WFCNegative Net Change JPMNegative Net Change CNegative Net Change
artificial-intelligence dividends e-commerce earnings inflation internet investing large-cap magnificent-7 retail tech-stocks
Can Tech & Mega-Caps Take Stocks Even Higher?
by John Blank
This is perhaps the biggest worry, now.
GEPositive Net Change NVDAPositive Net Change SCCOPositive Net Change
large-cap
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
by Zacks Equity Research
Pfizer, Johnson & Johnson and Eli Lilly are part of the Zacks top Analyst Blog.
JNJPositive Net Change PFEPositive Net Change LLYPositive Net Change
large-cap pharmaceuticals
Time to Buy Broadcom's (AVGO) Stock After Strong Q2 Results?
by Shaun Pruitt
Spiking over +15% in early morning trading, Broadcom's (AVGO) stock hit all-time highs today as AI helped the semiconductor titan post stellar growth for its fiscal second quarter.
AVGOPositive Net Change NVDAPositive Net Change
artificial-intelligence earnings investing large-cap semiconductor tech-stocks
Tesla Upcoming Shareholder Vote: Will Elon Musk Get Paid?
by Andrew Rocco
Tesla's crucial shareholder vote on CEO Elon Musk's pay package looms. Will shareholders vote yes or no, and what are the implications?
FNegative Net Change AAPLNegative Net Change TMNegative Net Change GMNegative Net Change TSLANegative Net Change PYPLNegative Net Change STLANegative Net Change
electric-vehicles investing large-cap magnificent-7